Reliable, inclusive, and tailored healthcare solutions.

For nearly two decades, this philosophy has shaped our investing approach. Whether advancing cutting-edge cancer therapies, scaling behavioral health to meet rising demand, or keeping patients active with innovative orthopedic solutions, every TPG Healthcare investment focuses on building and expanding companies that deliver greater value to the healthcare system and better outcomes for patients. Over our history, we’ve deployed more than $21 billion across 25+ companies; even in an exceptionally challenging year, we’re proud of the impact and growth across our portfolio and energized by the opportunities ahead. Today, our 13 active portfolio companies are introducing new models, products, and services that elevate patient care, improve efficiency, and drive breakthrough innovation throughout the system. Powered by 86,000+ physicians, researchers, clinicians, scientists, and healthcare professionals serving communities worldwide, this collective forms a dynamic ecosystem comparable in scale to a top-20 healthcare company in the S&P 500. Scroll down to explore how this evolving network is shaping, improving, and transforming care delivery.

Nearly Two Decades of Partnership
Nearly Two Decades of Partnership

Breakthrough Innovation

Allogene Therapeutics (NASDAQ: ALLO) is a clinical-stage biotechnology company with a single-minded focus on pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. These off-the-shelf therapies, enhanced by gene editing, could be the next vital breakthrough in the field of cancer treatment, making cell therapy faster, more reliable, and available at greater scale to more patients.

about images
In 2018, TPG partnered with Dr. Arie Belldegrun, founder of Kite Pharma, and Dr. David Chang, Head of R&D and Chief Medical Officer of Kite Pharma, to acquire Pfizer’s allogeneic CAR T portfolio and stand up Allogene as a fully functioning, independent company. Six months after formation, the company went public, making it one of the fastest and largest listings on record in biotechnology.

In under three years, Allogene has gone from launch to leadership in the allogeneic CAR T field. The company has advanced three therapeutic candidates into human clinical trials, including two therapies for relapsed/refractory non-Hodgkin lymphoma, and one for relapsed/refractory multiple myeloma. In 2021, Allogene expects to enter into a pivotal trial in relapsed/refractory non-Hodgkin lymphoma and initiate its first trial for allogeneic CAR T therapies in solid tumors. The company is also building a state-of-the-art, 120,000 square-foot manufacturing facility to ensure that patients will have access to their therapies.
about images

Breakthrough Innovation

Mental health is, in many ways, a largely unspoken pandemic. Mental illness rates are at epidemic levels and rising, affecting nearly 70 million Americans—about one in five. Even as stigma declines and awareness of broader health impacts grows, access to outpatient behavioral care remains severely limited: only 26 million receive treatment today. The need has intensified further during the COVID-19 pandemic.

In 2018, TPG partnered with Dr. Arie Belldegrun, founder of Kite Pharma, and Dr. David Chang, Head of R&D and Chief Medical Officer of Kite Pharma, to acquire Pfizer’s allogeneic CAR T portfolio and stand up Allogene as a fully functioning, independent company. Six months after formation, the company went public, making it one of the fastest and largest listings on record in biotechnology.

In under three years, Allogene has gone from launch to leadership in the allogeneic CAR T field. The company has advanced three therapeutic candidates into human clinical trials, including two therapies for relapsed/refractory non-Hodgkin lymphoma, and one for relapsed/refractory multiple myeloma. In 2021, Allogene expects to enter into a pivotal trial in relapsed/refractory non-Hodgkin lymphoma and initiate its first trial for allogeneic CAR T therapies in solid tumors. The company is also building a state-of-the-art, 120,000 square-foot manufacturing facility to ensure that patients will have access to their therapies.

Better Cost of Care

Kelsey-Seybold Clinic is the largest independent, multi-specialty physician group in the Houston area. The clinic comprises more than 480 physicians and allied health professionals practicing across 55+ specialties and caring for over 400,000 unique patients annually. Since 1949, Kelsey-Seybold has delivered high-quality care at lower total medical cost through a coordinated, evidence-based approach, earning accreditation from the National Committee for Quality Assurance (NCQA) as the nation’s first Accountable Care Organization and Houston’s longest-standing ACO recognition.

about images
Kelsey-Seybold’s accountable care model has delivered proven lower total healthcare costs for employers when compared to other HMO and PPO commercial health plans in the Greater Houston area, while also providing the highest possible quality of care and an excellent patient experience. In addition to its fee-for-service patient care business, Kelsey-Seybold operates its own Medicare Advantage health plan (KelseyCare Advantage) and partners with major insurance carriers to provide commercial capitated or risk-based health plans (KelseyCare) to area employers. KelseyCare Advantage is one of three 5-star plans in Texas and is the only health plan in the state to be rated 5-out-of-5 stars by Medicare five years in a row, starting in 2017.
Escalating healthcare costs continue to be one of the biggest challenges facing the nation’s healthcare system. Kelsey-Seybold’s accountable care model represents an innovative and forward-looking approach to care delivery and payment reimbursement. TPG invested in Kelsey-Seybold in January 2020.

Our expert team

counter-icon
11 M+

Patient Visits Annually

counter-icon
500 M

Invested in R&D per Year

counter-icon
9 M+

People Served Annually (Services & IT)

Our Companies

image of service

Adare Pharmaceuticals

Global, technology-driven contract development and manufacturing organization (CDMO)

Adarepharmasolutions.com
image of service

Allogene Therapeutics

Pioneer in allogeneic cell therapies for cancer

Allogene.com
image of service

Amneal

Integrated generics and specialty pharmaceutical platform

Amneal.com
image of service

AskBio

Fully integrated AAV gene therapy innovator and manufacturer

Askbio.com
image of service

BGB Group

Provider of integrated commercialization services to pharma and biotech client | Serves more than 100 brands, including 15 of the top 25 pharma companies

bgbgroup.com
image of service

Biomet

Reconstructive products for orthopedics and other musculoskeletal specialists

Zimmerbiomet.com
image of service

BVI

Global ophthalmic medical device manufacturer

Bvimedical.com
image of service

Confluent Medical

Materials science expert designing and manufacturing specialized medical device components used in mission-critical surgical procedures

Confluentmedical.com
image of service

Convey Health Solutions

Tech-enabled solutions for insurance plans

Conveyhealthsolutions.com
image of service

Covetrus

Animal-health technology and services company dedicated to empowering veterinarians through practice management software and online pharmacy solutions

Covetrus.com
image of service

Doc Pharma

Leading generics pharmaceuticals company based in Milan | 60M products sold annually across Italy’s 20K pharmacies

Docpharma.com
image of service

Ellodi Pharmaceuticals

Gastroenterology-focused specialty pharmaceutical company | In late-stage clinical trial for a treatment for Eosinophilic Esophagitis, a disease for which there are no approved treatments today

Ellodipharma.com
image of service

Fenwal

Medical technology innovator in transfusion medicine

New Transfusion Therapies Company to Be Named Fenwal
image of service

Healthscope

A leading private healthcare provider in Australia

Healthscope.com.au
image of service

Immucor

Global provider of transfusion and transplant diagnostic products

Immucor.com
image of service

IQVIA

A leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry

Iqvia.com
image of service

Kelsey-Seybold Clinic

Largest independent multi-specialty physician group in Greater Houston with a leading Medicare Advantage health plan

Kelsey-seybold.com
image of service

Kindred At Home

Largest home health and hospice provider in the U.S. with 9M+ patient visits per year

Kindredhealthcare.com
image of service

Kindred Healthcare

A leading specialty hospital company focused on inpatient rehabilitation, long-term acute care, and behavioral facilities

Kindredhealthcare.com
image of service

LifeStance Health

Largest outpatient mental health provider in the U.S.

Lifestance.com
image of service

Lyric

Leading payment integrity software provider carved out from Change Healthcare that enables health plans to edit clinical claims, reducing fraud, waste, and abuse

Lyric.ai
image of service

Monogram Health

Value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease

Monogramhealth.com
image of service

Nextech

A leading provider of clinical and administrative healthcare technology solutions for specialty physician practices

nextech.com
image of service

OneOncology

Platform of leading oncology practices

oneoncology.com
image of service

PAR Pharmaceutical

Manufacturer of generic pharmaceutical and branded injectable products

Parpharm.com
image of service

Surescripts

A leading healthcare IT network that connects nearly all providers, payors, and pharmacies in the US

Surescripts.com
image of service

Surgical Care Affiliates

A leading outpatient surgery center provider

Scasurgery.com
image of service

WellSky

Technology company advancing human wellness worldwide

Wellsky.com
Delivering high-quality healthcare relies on building great companies. For nearly two decades, we’ve been partnering with outstanding management teams to do just that. Learn more about some of our franchise-defining partnerships:

our latest news